Abcam, ab319046, Anti-Dynorphin A antibody [EPR28632-17] - BSA and Azide free

Size: 100µg / 1mg
Rabbit Recombinant Monoclonal ProDynorphin antibody. Carrier free. Suitable for Dot, IHC-P, ICC/IF, IHC-Fr and reacts with Synthetic peptide - Mouse, Mouse, Rat samples.
Key facts
Host species:Rabbit,
Clonality:Monoclonal,
Clone number:EPR28632-17,
Isotype:IgG,
Carrier free:Yes,
Reacts with:Mouse, Rat,
Applications:IHC-Fr, Dot, ICC/IF, IHC-PSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:The exact immunogen used to generate this antibody is proprietary information.,
Specificity:This clone works only in the hippocampus of mouse and rat. Unsuitable for rat ICC.

Product details:
ab319046 is the carrier-free version of
ab319045
Patented technology
Our RabMAb
technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to
RabMAb® patents
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production
For more information, read more on
recombinant antibodies
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our
conjugation kits
for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar
Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar
is a trademark of Fluidigm Canada Inc.

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Protein A, Storage buffer-pH: 7.2 - 7.4Constituents: PBS, Shipped at conditions-Blue Ice, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions-+4°C

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
Dynorphin A also known as Dynorphin-1 or Dyn A is an opioid peptide that acts as a neurotransmitter. It is part of the endorphin enkephalin and dynorphin family of opioid peptides which play significant roles in the modulation of pain and emotion. Dynorphin A consists of 17 amino acids and has a mass of approximately 2 kDa. Its expression is prominent in the central nervous system including the brain and spinal cord where it interacts with kappa-opioid receptors to regulate various physiological processes.
Biological function summary
Dynorphin peptides including Dynorphin A act as modulators of nociceptive pathways influencing the perception of pain. As an agonist of kappa-opioid receptors Dynorphin A produces analgesic effects by inhibiting neurotransmitter release in the central nervous system. Although it does not mainly form part of a complex Dynorphin A may stimulate the release or inhibition of other neurotransmitters such as dopamine affecting mood and stress responses.
Pathways
Several key physiological activities involve Dynorphin A. It influences the opioid system pathway where it plays important roles in pain modulation and mood regulation. Dynorphin A also interacts with the stress response pathways particularly impacting the hypothalamic-pituitary-adrenal (HPA) axis. It shares pathways with other neurotransmitters and proteins such as endorphins and enkephalins which also target opioid receptors.
Dynorphin A relates to conditions like addiction and depression. It contributes to the dysregulation of neurotransmitter systems which is a factor in these disorders. Dynorphin A modulates dopamine release involved in reward pathways influencing addiction development. In mood disorders it connects with stress hormones and peptides affecting mental health outcomes. Associations with proteins like corticotropin-releasing factor further link it to how the body manages stress potentially contributing to depressive states.